Sara Wilhelmien Quist

8PUBLICATIONS
3CO-AUTHORS
NanomedicineClinical nutritionVision scienceAgricultural molecular engineering of nucleic acids and proteinsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 22, 2025
Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland.

Aude Ambresin, S W Quist, M Boer

|Jun 27, 2025
Cost-effectiveness of treatment with finerenone in mild to advanced stage chronic kidney disease patients with type 2 diabetes from a societal perspective.

Sara Wilhelmien Quist, Jeanni van Loon, Stephan Bakker

|Jun 07, 2025
Anti-VEGFs for Diabetic Macular Oedema: Analysis of Efficacy, Safety, and Cost of More Durable Therapies from a Dutch Societal Perspective.

Sara W Quist, Jeroen H J Paulissen, Izabella Lunk

|Sep 25, 2024
A cost-minimization analysis of anti-VEGFs for the treatment of neovascular age-related macular degeneration in the Netherlands.

Sara W Quist, Hidde Nab, Maarten Postma

|Aug 20, 2024
Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens.

Sara W Quist, Sophie Te Dorsthorst, Roel D Freriks

|Mar 11, 2023
Costs of radium-223 and the pharmacy preparation 177Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitals.

S W Quist, J H J Paulissen, D N J Wyndaele

Pageof 2

Frequent Collaborators

1 joint publications

J H J Paulissen

1 joint publications

J Nagarajah

1 joint publications

R D Freriks